114 related articles for article (PubMed ID: 11312617)
21. Characterization of the Vibrio cholerae vexAB and vexCD efflux systems.
Bina JE; Provenzano D; Wang C; Bina XR; Mekalanos JJ
Arch Microbiol; 2006 Sep; 186(3):171-81. PubMed ID: 16804679
[TBL] [Abstract][Full Text] [Related]
22. Cell wall antigens in Vibrio cholerae O139 Bengal, a causative agent of new epidemics.
Weintraub A; Jansson PE; Jansson M; Paredes L; Hultenby K; Widmalm G; Albert MJ
Prog Clin Biol Res; 1995; 392():141-50. PubMed ID: 8524919
[No Abstract] [Full Text] [Related]
23. Investigation of populations heterogeneous according to O-antigen in Vibrio cholerae cultures.
Andrusenko IT; Aleksandrova IK; Pidtilok EA; Ved'mina EA; Givental' NI; Pasternak NA; Shenderovich VA; Sobolev VR
J Hyg Epidemiol Microbiol Immunol; 1984; 28(2):177-84. PubMed ID: 6206130
[TBL] [Abstract][Full Text] [Related]
24. [Cholera pathogens from the new serogroup O139: molecular-genetic features and origin].
Smirnova NI
Mol Gen Mikrobiol Virusol; 2002; (3):23-33. PubMed ID: 12243062
[TBL] [Abstract][Full Text] [Related]
25. Differential immunogenicity of Vibrio cholerae O139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide.
Attridge SR; Wallerström G; Li BL; Morona R; Holmgren J
Vaccine; 2009 Feb; 27(7):1055-61. PubMed ID: 19100303
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterisation of rough strains of Vibrio cholerae isolated from diarrhoeal cases in India and their comparison to smooth strains.
De K; Ramamurthy T; Faruque SM; Yamasaki S; Takeda Y; Nair GB; Nandy RK
FEMS Microbiol Lett; 2004 Mar; 232(1):23-30. PubMed ID: 15019730
[TBL] [Abstract][Full Text] [Related]
27. [The use of liposomes for detection of the surface lipopolysaccharide antigen, Vibrio cholerae cells, and antibodies against them].
Skopinskaia SN; Iarkov SP; Khramov EN
Prikl Biokhim Mikrobiol; 2005; 41(2):228-34. PubMed ID: 15859469
[TBL] [Abstract][Full Text] [Related]
28. [Some immunochemical and immunobiological properties of Vibrio cholerae serovar 0139 capsule antigen].
Fedorova VA; Devdariani ZL; Gromova OV; Livanova LF
Mol Gen Mikrobiol Virusol; 1997; (3):18-20. PubMed ID: 9297105
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic and molecular typing of Vibrio cholerae O1 and O139 isolates from India.
Bhowmick TS; Das M; Roy N; Sarkar BL
J Infect; 2007 May; 54(5):475-82. PubMed ID: 17087996
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis.
Attridge SR; Qadri F; Albert MJ; Manning PA
Clin Diagn Lab Immunol; 2000 May; 7(3):444-50. PubMed ID: 10799459
[TBL] [Abstract][Full Text] [Related]
31. Role of Vibrio cholerae O139 surface polysaccharides in intestinal colonization.
Nesper J; Schild S; Lauriano CM; Kraiss A; Klose KE; Reidl J
Infect Immun; 2002 Nov; 70(11):5990-6. PubMed ID: 12379674
[TBL] [Abstract][Full Text] [Related]
32. [Identification and molecular study on vibrio cholerae in sea products].
Chang ZR; Zhang J; Wang DC; Zhong HJ; Xu J; Ran L; Wang MW; Wang ZJ; Kan B
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jul; 41(4):304-6. PubMed ID: 17959056
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a clinical Vibrio cholerae O139 isolate from Mexico.
Parveen S; Farrah SR; Gonzalez-Bonilla C; Zamudio AV; Tamplin ML
Can J Microbiol; 2003 Jan; 49(1):65-70. PubMed ID: 12674350
[TBL] [Abstract][Full Text] [Related]
34. [Differences in virulence genes in Vibrio cholerae eltor strains isolated from different sources in Turkmenistan territory].
Smirnova NI; Kostromitina EA; Cheldyshova NB; Kutyrev VV
Mol Gen Mikrobiol Virusol; 2002; (4):12-8. PubMed ID: 12534264
[TBL] [Abstract][Full Text] [Related]
35. Characterization of vibrio cholerae O1 antigen as the bacteriophage K139 receptor and identification of IS1004 insertions aborting O1 antigen biosynthesis.
Nesper J; Kapfhammer D; Klose KE; Merkert H; Reidl J
J Bacteriol; 2000 Sep; 182(18):5097-104. PubMed ID: 10960093
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of the rstR and orfU genes of the CTX prophages integrated in the small chromosomes of environmental Vibrio cholerae non-O1, non-O139 strains.
Bhattacharya T; Chatterjee S; Maiti D; Bhadra RK; Takeda Y; Nair GB; Nandy RK
Environ Microbiol; 2006 Mar; 8(3):526-634. PubMed ID: 16478458
[TBL] [Abstract][Full Text] [Related]
37. Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with enteritis in Ceará, Brazil.
Hofer E; Reis EM; Quintaes BR; Rodrigues DP; Feitosa IS; Angelo MR; Ribeiro LH
J Health Popul Nutr; 2001 Mar; 19(1):39-42. PubMed ID: 11394182
[TBL] [Abstract][Full Text] [Related]
38. Conformation of the hexasaccharide repeating subunit from the Vibrio cholerae O139 capsular polysaccharide.
Adeyeye J; Azurmendi HF; Stroop CJ; Sozhamannan S; Williams AL; Adetumbi AM; Johnson JA; Bush CA
Biochemistry; 2003 Apr; 42(13):3979-88. PubMed ID: 12667089
[TBL] [Abstract][Full Text] [Related]
39. Identification of additional genes required for O-antigen biosynthesis in Vibrio cholerae O1.
Fallarino A; Mavrangelos C; Stroeher UH; Manning PA
J Bacteriol; 1997 Apr; 179(7):2147-53. PubMed ID: 9079898
[TBL] [Abstract][Full Text] [Related]
40. Regions of the cloned Vibrio cholerae rfb genes needed to determine the Ogawa form of the O-antigen.
Morona R; Matthews MS; Morona JK; Brown MH
Mol Gen Genet; 1990 Dec; 224(3):405-12. PubMed ID: 1702506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
